Cipla beats quarterly profit view on strong demand
Cipla beats profit estimates with strong demand for chronic condition drugs, faces supply chain issues for tumour drug.
Source
Cipla beats profit estimates with strong demand for chronic condition drugs, faces supply chain issues for tumour drug.
Source